Morgan Stanley
-
-
-
-
-
-
-
Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
-
-
-
-
-
-
-
Novo Nordisk (NVO) -13% after 'worst case' REDEFINE-4 readout; LLY +4%
-
-
-
-
-
-
-
Morgan Stanley on Compounder Lawsuits: 'experts think the courts would likely refuse to dismiss the case and that it could take 2-3 years to resolve'
-
-
-
-
-
-
-
Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program
-
-
-
-
-
-
-
Morgan Stanley on Eli Lilly (LLY): 'we expect LLY shares to trade flat to slightly up'
-
-
-
-
-
-
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Fed, Apple and NFP in spotlight
-
-
-
-
-
-
-
Morgan Stanley presents '30 for 2025' list consisting of best LT picks
-
224,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

